Acrivon Therapeutics, Inc. Common Stock (ACRV) financials · $65.1M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Acrivon Therapeutics, Inc. Common Stock (ACRV) $65.1M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$84.1M | -$89.2M |
| Net Income | -$77.9M | -$80.6M |
| EPS (Diluted) | -$2.02 | -$2.38 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $129.7M | $196.6M |
| Current Assets | $120.4M | $181.6M |
| Cash & Equivalents | $41.5M | $39.8M |
| PP&E | $4.89M | $4.47M |
| Total Liabilities | $17.2M | $19.8M |
| Current Liabilities | $15.7M | $17.2M |
| Shareholders' Equity | $112.5M | $176.8M |
| Retained Earnings | -$274.9M | -$197.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$63.7M | -$65.7M |
| CapEx | $1.67M | $2.77M |
| Investing Cash Flow | $66.1M | -$51.8M |
| Financing Cash Flow | -$749.0K | $121.0M |
| Net Change in Cash | $1.69M | $3.59M |
| Free Cash Flow | -$65.3M | -$68.4M |
FAQ
What is ACRV P/E and revenue?
Acrivon Therapeutics, Inc. Common Stock (ACRV) $65.1M cap.
What is ACRV revenue?
ACRV income-statement cache has no revenue figure yet.
Is ACRV profitable?
Acrivon Therapeutics, Inc. Common Stock last cached net income is -$77.9M (FY2025).
What are ACRV total assets?
Acrivon Therapeutics, Inc. Common Stock last cached total assets are $129.7M (FY2025).
What is ACRV free cash flow?
Acrivon Therapeutics, Inc. Common Stock last cached free cash flow is -$65.3M (FY2025).
Not investment advice. Cached statements, not a live tape.